This 2023 expert consensus outlines best practices for utilizing anti-double-stranded DNA (anti-dsDNA) autoantibodies in diagnosing and monitoring systemic lupus erythematosus (SLE). While anti-dsDNA antibodies are integral to SLE classification and disease activity assessment, their clinical utility is hindered by assay heterogeneity, lack of standardization, and variable specificity across populations. The
